CCocoon Bioscience — Series A · €2M
Cocoon Bioscience, which uses cocooned insects as bioreactors to produce enzymes and growth factors for pharma and cultivated meat, raised €2 million co-led by MONDRAGON and Bexen Medical, with existing backers Columbus Venture Partners, Cleon Capital, Viscofan, North South Ventures, Sangha Capital and Basque public fund SPRI following on. The money funds a new manufacturing plant at the Bizkaia Technology Park in Zamudio and follows the company's earlier €15M round led by Columbus and Cleon, so it is effectively a Series A extension; because two investors co-led, no single lead is recorded.
LeadMondragon Corporation, Bexen Medical
RoundSeries A
Announced3 Nov 2023
CityBilbao · reported Madrid
SectorHealthtech & Bio · Biotech / Industrial biotechnology
Source
W
C
W
C
The company
Investors 8
BBexen Medical
MMONDRAGON
www.mondragon-corporation.com
CCleon Capital
CColumbus Venture Partners
columbusvp.com
N
North South Ventures
SSangha Capital
SSPRI
www.spri.eus
V
Viscofan
www.viscofan.com